Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes.
Nagata Y, Narumi S, Guan Y, Przychodzen BP, Hirsch CM, Makishima H, Shima H, Aly M, Pastor V, Kuzmanovic T, Radivoyevitch T, Adema V, Awada H, Yoshida K, Li S, Sole F, Hanna R, Jha BK, LaFramboise T, Ogawa S, Sekeres MA, Wlodarski MW, Cammenga J, Maciejewski JP. Nagata Y, et al. Among authors: adema v. Blood. 2018 Nov 22;132(21):2309-2313. doi: 10.1182/blood-2017-05-787390. Epub 2018 Oct 15. Blood. 2018. PMID: 30322869 Free PMC article. No abstract available.
Paraffin treasures: do they last forever?
Ademà V, Torres E, Solé F, Serrano S, Bellosillo B. Ademà V, et al. Biopreserv Biobank. 2014 Aug;12(4):281-3. doi: 10.1089/bio.2014.0010. Epub 2014 Jul 30. Biopreserv Biobank. 2014. PMID: 25075953
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.
Schneider RK, Ademà V, Heckl D, Järås M, Mallo M, Lord AM, Chu LP, McConkey ME, Kramann R, Mullally A, Bejar R, Solé F, Ebert BL. Schneider RK, et al. Among authors: adema v. Cancer Cell. 2014 Oct 13;26(4):509-20. doi: 10.1016/j.ccr.2014.08.001. Epub 2014 Sep 18. Cancer Cell. 2014. PMID: 25242043 Free PMC article.
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations.
Adema V, Larráyoz MJ, Calasanz MJ, Palomo L, Patiño-García A, Agirre X, Hernández-Rivas JM, Lumbreras E, Buño I, Martinez-Laperche C, Mallo M, García O, Álvarez S, Blazquez B, Cervera J, Luño E, Valiente A, Vallespí MT, Arenillas L, Collado R, Pérez-Oteyza J, Solé F. Adema V, et al. Br J Haematol. 2015 Oct;171(1):137-41. doi: 10.1111/bjh.13355. Epub 2015 Feb 25. Br J Haematol. 2015. PMID: 25716545 Free article. No abstract available.
Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes.
Sánchez-Castro J, Marco-Betés V, Gómez-Arbonés X, García-Cerecedo T, López R, Talavera E, Fernández-Ruiz S, Ademà V, Marugan I, Luño E, Sanzo C, Vallespí T, Arenillas L, Marco Buades J, Batlle A, Buño I, Martín Ramos ML, Blázquez Rios B, Collado Nieto R, Vargas MT, González Martínez T, Sanz G, Solé F; Spanish Group for Mds Study (GESMD); Spanish Group for Clinical Cytogenetics (Gcecgh). Sánchez-Castro J, et al. Among authors: adema v. Leuk Lymphoma. 2015;56(11):3183-8. doi: 10.3109/10428194.2015.1028053. Epub 2015 May 12. Leuk Lymphoma. 2015. PMID: 25754580
Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases.
Palomo L, Xicoy B, Garcia O, Mallo M, Ademà V, Cabezón M, Arnan M, Pomares H, José Larrayoz M, José Calasanz M, Maciejewski JP, Huang D, Shih LY, Ogawa S, Cervera J, Such E, Coll R, Grau J, Solé F, Zamora L. Palomo L, et al. Among authors: adema v. Am J Hematol. 2016 Feb;91(2):185-92. doi: 10.1002/ajh.24227. Epub 2015 Dec 9. Am J Hematol. 2016. PMID: 26509444 Free article.
Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide.
Negoro E, Radivoyevitch T, Polprasert C, Adema V, Hosono N, Makishima H, Przychodzen B, Hirsch C, Clemente MJ, Nazha A, Santini V, McGraw KL, List AF, Sole F, Sekeres MA, Maciejewski JP. Negoro E, et al. Among authors: adema v. Leukemia. 2016 Dec;30(12):2405-2409. doi: 10.1038/leu.2016.228. Epub 2016 Aug 18. Leukemia. 2016. PMID: 27560106 Free PMC article. No abstract available.
Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome Patients.
Palomo L, Fuster-Tormo F, Alvira D, Ademà V, Armengol MP, Gómez-Marzo P, de Haro N, Mallo M, Xicoy B, Zamora L, Solé F. Palomo L, et al. Among authors: adema v. Biopreserv Biobank. 2017 Aug;15(4):360-365. doi: 10.1089/bio.2016.0094. Epub 2017 Jun 6. Biopreserv Biobank. 2017. PMID: 28586236
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes.
Nazha A, Al-Issa K, Hamilton BK, Radivoyevitch T, Gerds AT, Mukherjee S, Adema V, Zarzour A, Abuhadra N, Patel BJ, Hirsch CM, Advani A, Przychodzen B, Carraway HE, Maciejewski JP, Sekeres MA. Nazha A, et al. Among authors: adema v. Leukemia. 2017 Dec;31(12):2848-2850. doi: 10.1038/leu.2017.266. Epub 2017 Aug 18. Leukemia. 2017. PMID: 28819282 No abstract available.
Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms.
Balasubramanian SK, Aly M, Nagata Y, Bat T, Przychodzen BP, Hirsch CM, Adema V, Visconte V, Kuzmanovic T, Radivoyevitch T, Nazha A, Mukherjee S, Sekeres MA, Maciejewski JP. Balasubramanian SK, et al. Among authors: adema v. Leukemia. 2018 Feb;32(2):550-553. doi: 10.1038/leu.2017.295. Epub 2017 Sep 22. Leukemia. 2018. PMID: 28935992 Free PMC article. No abstract available.
54 results